Dublin, 10 Feb. 2022 (GLOBE NEWSWIRE) — The “Global Space OMICS Market, By Sample Type, By End Use, By Technology, By Product, By Workflow, Estimate & Forecast, 2018 – 2028” report has been added to from ResearchAndMarkets.com offer.
The global Space OMICS Market held a market value of USD 230.2 Million in 2020 and is projected to reach USD 506.6 Million by 2028. The market is expected to register a CAGR of 10.3% during the forecast period.
Spatial omics combines molecular examination with spatial data on the location of the cell inside the tissue. Omics is a term for many diverse studies, such as epigenomics, genomics, transcriptomics, lipidomics proteomics, and metabolomics, among others.
Space OMICS market drivers include high applications as diagnostic tools, especially in the field of oncology. Rising prevalence and incidence rates of cancer are driving the growth of the market. Additionally, high research and development conducted by private and public agencies is driving the growth of the market. For example, Ting Wu, professor of genetics at Harvard Medical School’s (HMS) Blavatnik Institute, has created innovations that multiplex Oligopaint pipeline protocols and reagent methods, combined with analysis techniques to generate a shorter and more costly time to obtain results. effective approach to envisioning the genome unwaveringly, spatially and in situ. Many aspects of this ability were highlighted in a 2020 publication in Nature Methods, generating a high level of awareness.
On the other hand, lack of skilled technical professionals in developing, underdeveloped and even few developing countries is hampering the growth rate of this industry.
Growing potential of spatial OMICS as a diagnostic tool for cancer
Many emerging space OMICS technologies and advancements are contributing to the growth of the space OMICS market. For example, spatial transcriptomics (ST) is an in situ capture method, allowing the quantification and visualization of transcriptomes in individual tissue sections. The application of space-based OMICS techniques in cancer diagnosis promises tremendous results in the near future.
Growing adoption of spatial OMICS in drug discovery and development
Companies use spatial OMICS to understand molecules during clinical trial studies. Drug discovery is a crucial phase in global clinical studies, and the use of space OMICS in the drug development and discovery phases contributes substantial growth currently and in the near future for the market. Space OMICS over the forecast period. For example, Nanostring’s Cancer Transcriptome Atlas is GeoMx’s first commercial read-enabled product using NGS. It includes over 1,800 genes and 100 pathways and offers 20x RNA coverage, giving a high-resolution spatial view of cancer biology.
Presentation of the segments:
The global space OMICS market is segmented into sample type, end use, technology, product, and workflow.
By sample type
The FFPE segment holds the largest market share of around 55% due to the increase in examinations, experimental research and advancements in diagnosis. Additionally, the fresh frozen food segment is expected to experience the fastest growth owing to the steady increase in demand.
By end use
- Academic and translational research institutes
- Pharmaceutical and biotechnology companies
The academic and translational research institutes segment held the largest share due to an increase in government grants, funds for research, as well as an increased focus of research in spatial genomics and other fields.
- Spatial proteomics
- Spatial transcriptomics
- Spatial genomics
The space genomics segment is expected to experience the fastest growth with a CAGR of 12.3% due to the increase in chronic diseases. The launch of new tools and instruments in this field is driving the growth of this segment.
The consumables segment is expected to hold a substantial share and surpass the market value of $200 million by 2026. The growing usage of consumables coupled with the rise in applications of spatial transcriptomics in many fields including drug discovery, drug development and biomarker identification, is driving the growth of this segment. segment.
- Sample preparation
- Instrumental analysis
- Data analysis
The sample preparation segment is estimated to be the fastest growing segment owing to the increase in research studies and drug candidates from clinical trials. The market value of the segment is expected to reach USD 154 million in 2028.
By region, the global space OMICS market is divided into Europe, North America, Asia-Pacific, Middle East & Africa and South America.
The Asia-Pacific region is expected to experience the fastest growth at the rate of 11.4% in the spatial OMICS market owing to the high adoption rate of in situ sequencing techniques in research-driven countries, such as the Japan, Australia and India. Furthermore, the European region is expected to grow at a substantial rate due to the increasing awareness regarding spatial proteomics and the field of transcriptomics. Moreover, the Latin America, Middle East and Africa region is also expected to grow at a considerable rate. The Middle East and Africa market value is expected to exceed USD 10 million by 2027.
Key players operating in the global spatial OMICS market include 10x Genomics, S2 Genomics, Inc., NanoString Technologies, Seven Bridges Genomics, PerkinElmer, Inc., Bio-Techne, Danaher Corporation, IonPath Inc., Millennium Science Pty Ltd, Akoya Biosciences, Inc., Fluidigm Corporation, Diagenode Diagnostics, Biognosys AG, Rebus Biosystems. Ultivue Inc, BioSpyder Technologies and Bruker, among others.
The top 6 market players hold around 64% of the market share. These market players invest in product launches, collaborations, mergers and acquisitions, and expansions to create a competitive advantage in the market. For example, in June 2020, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, introduced new solutions for studying the immune response in cancer research. COVID-19 disease.
The global Space OMICS market report provides information about the pointers below:
- Market Penetration: Provides comprehensive market insights offered by major players
- Market Development: The report offers detailed information on lucrative emerging markets and analyzes penetration in mature segments of the markets.
- Market Diversification: Provides detailed information on untapped geographies, recent developments and investments
- Competitive Landscape Assessment: Mergers and acquisitions, certifications, product launches in the global Space OMICS market have been provided in this research report. In addition, the report also emphasizes on the SWOT analysis of key players.
- Product Development and Innovation: The report provides smart insights into future technologies, R&D activities and breakthrough product developments
- Price Analysis: Price analysis of various metals and other components used in the manufacture of space OMICS products
- Manufacturing cost analysis: Cost sharing of various components in spatial OMICS, cost analysis of spatial OMICS tools
The global space OMICS market report answers questions such as:
- What is the market size and forecast of the global Space OMICS market?
- What are the inhibiting factors and impact of COVID-19 on the Global Space OMICS Market during the assessment period?
- What are the products/segments/applications/areas to invest in during the assessment period in the Global Space OMICS Market?
- What is the competitive strategic window for opportunities in the Global Space OMICS Market?
- What are the technology trends and regulatory frameworks in the global Space OMICS market?
- What is the market share of the major players in the global space OMICS market?
- What modes and strategic moves are considered favorable for entering the global space OMICS market?
Main topics covered:
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 3. Executive Summary: Global Spatial OMICS Market
Chapter 4. Global Space OMICS Market Overview
4.1.1. Growing potential of spatial OMICS as cancer diagnostic tools
4.1.2. Growing adoption of spatial OMICS in drug discovery and development
4.2.1. Lack of qualified professionals
4.3.1. Growing use of spatial OMICS for biomarker identification
4.4. Impact of COVID-19 on the Space OMICS Market
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining power of suppliers
4.5.2. The bargaining power of buyers
4.5.3. The threat of substitutes
4.5.4. The threat of new entrants
4.5.5. degree of competition
Chapter 5. Spatial OMICS Market Analysis, By Sample Type
5.1. key ideas
5.2. Market Size and Forecast, 2018-2028 (Million USD)
5.2.2. Fresh Frozen
Chapter 6. Space OMICS Market Analysis, By End Use
6.1. key ideas
6.2. Market Size and Forecast, 2018-2028 (Million USD)
6.2.1. Academic and translational research institutes
6.2.2. Pharmaceutical and biotechnology companies
Chapter 7. Space OMICS Market Analysis, By Technology
7.1. key ideas
7.2. Market Size and Forecast, 2018-2028 (Million USD)
7.2.1. Spatial proteomics
7.2.2. Spatial transcriptomics
7.2.3. Spatial genomics
Chapter 8. Spatial OMICS Market Analysis, By Product
8.1. key ideas
8.2. Market Size and Forecast, 2018-2028 (Million USD)
Chapter 9. Spatial OMICS Market Analysis, By Workflow
9.1. key ideas
9.2. Market Size and Forecast, 2018-2028 (Million USD)
9.2.1. Sample preparation
9.2.2. Instrumental analysis
9.2.3. Data analysis
Chapter 10. Space OMICS Market Analysis, By Region/Country
Chapter 11. North America Spatial OMICS Market Analysis
Chapter 12. Europe Spatial OMICS Market Analysis
Chapter 13. Asia Pacific Space OMICS Market Analysis
Chapter 14. MEA Spatial OMICS Market Analysis
Chapter 15. Company Profile
For more information on this report, visit https://www.researchandmarkets.com/r/5sdbfo